Competitive market analysis of transplant centers and discrepancy of wait-listing of recipients for kidney transplantation

International Journal of Organ Transplantation Medicine

Volumn 6, Issue 4, 2015, Pages 142-149

  Cho, P S ^a   Saidi, Reza F ^b   Cutie, C J ^a   Ko, D S C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Allocation; Competition; Kidney transplantation; Market analysis; Wait list

Indexed keywords

ARTICLE; CONTROLLED STUDY; END STAGE RENAL DISEASE; GRAFT RECIPIENT; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH CENTER; HERFINDAHL HIRSCHMAN INDEX; HOSPITAL ADMISSION; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MARKETING; SCORING SYSTEM; UNITED STATES;

EID: 84944906935     PISSN: 20086482     EISSN: 20086490     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008. U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD. Available from: www.srtr.org/annual_reports/archives/ 2009/2009_Annual_Report.zip (Accessed December 15, 2013).
2. Klein AS, Messersmith EE, Ratner LE, et al. Organ donation and utilization in the United States, 1999- 2008. Am J Transplant 2010;10(4 Pt 2):973-86.
3. UNOS, United network for organ sharing. Available from: www.unos.gov/data (Accessed December 5, 2013).
4. Organ procurement and transplantation network. The Final Rule-Federal Regulation for the operation of the OPTN. DoHaH. Services. 2000. Available from: optn.transplant.hrsa.gov/policiesAnd- Bylaws/final_rule.asp (Accessed December 5, 2013).
5. Brown RS, Higgins R, Prutt TL. The Evolution and Direction of OPTN Oversight of Live Organ Donation and Transplantation in the United States. Am J Transplant 2009;9:31-4.
6. McDiarmid SV, Pruett TL, Graham WK. The Oversight of Solid Organ Transplantation in the United States. Am J Transplant 2008;8:739-44.
7. Hyman DA, Kovacic WE. Monopoly, monopsony, and market definition: an antitrust perspective on market concentration among health insurers. Health Aff 2004;23:25-8.
8. Nauenberg E, Alkhamisi M, Andrijuk Y. Simulation of a Herfindahl-Hirschmanindex without complete market share information. Health Econ 2004; 13:87-94.
9. Reuter J, Gaskin D. Academic Health Centers in Competitive Markets. Health Affairs 1997;16:242- 52.
10. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-Mismatched enal Transplantation Without Maintenance Immunosuppression. N Engl J Med 2008;358:353-61.
11. Kawai T, Sachs DH, Sykes M, Cosimi AB. Immune Tolerance Network. HLA-Mismatched Renal Transplantation Without Maintenance Immunosuppression. N Engl J Med 2013;368:1850-52.
12. Van Walraven C, Manuel DG, Knoll G. Survival Trends in ESRD Patients Compared With the General Population in the United States. Am J Kidney Dis 2014;63:491-9.
13. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999;341:1725-30.
14. Chapman J, Bock A, Dussol B, et al. Follow-up after renal transplantation with organs from donors after cardiac death. Transpl Int 2006;19:715-19.
15. Saidi RF, Elias N, Kawai T, et al. Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: realities and costs. Am J Transplant 2007;7:2769-74.
16. Whiting JF, Delmonico F, Morrissey P, et al. Clinical results of an organ procurement organization effort to increase utilization of donors after cardiac death. Transplantation 2006;81:1368-71.
17. Merion RM, Ashby VB, Wolfe RA, et al. Deceaseddonor characteristics and the survival bene?t of kidney transplantation. JAMA 2005;294:2726-33.
18. Saidi RF, Markmann JF, Jabbour N, et al. The Faltering Solid Organ Donor Pool in The United States (2001-2010). World J Surg 2012;36:2909-13.
19. Grady D, Meier B. A Transplant That Is Raising Many Questions. The New York Times, 22 June 2009 Available from: www.nytimes.com/2009/06/23/ business/23liver.html?_r=0 (Accessed December 15, 2013).
20. Scanlon DP, Hollenbeak CS, Lee W, et al. Does competition for transplantable hearts encourage 'gaming' of the waiting list? Health Aff 2004;23:191-8.
21. Halidorson JB, Paarsch HJ, Dodge JL, et al. Center Competition and Outcomes Following Liver Transplantation. Liver Transplantation ; 2013;19:96-104.
22. Axelrod DA, McCullough KP, Brewer ED, et al. Kidney and pancreas transplantation in the United States, 1999-2008: the changing face of living donation. Am J Transplant 2010;10(4 Pt 2):987-1002.
23. Garonzik-Wang JM, James NT, Weatherspoon KC, et al. The aggressive phenotype: center-level patterns in the utilization of suboptimal kidneys. Am J Transplant 2012;12:400-8.
24. Saidi RF, Khaksari S, Ko DSC. Effect of staff migration on kidney transplant volume in region 1. Progress in Transplantation 2014;24:298-301.
25. Centers for medicare and Medicaid services. Transplant Program Application Requirements Available from: www.cms.gov/Medicare/Provider- Enrollment-and-Certification/Certificationand- Complianc/Transplant.html (Accessed December 15, 2013).
26. Horizontal Merger Guidelines Available from www.justice.gov/atr/horizontal-merger-guidelines- 08192010 (Accessed December 15, 2013).